About DirectBio
DirectBio is a company based in San Francisco (United States) founded in 2023. It operates as a B2B. DirectBio offers products and services including CRISPR Diagnostics. DirectBio operates in a competitive market with competitors including ZYMVOL, Imperagen and Nanosyn, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DirectBio
DirectBio offers a comprehensive portfolio of products and services, including CRISPR Diagnostics.
Amplification-free tools for detecting airborne viruses accurately and quickly.
Funding Insights of DirectBio
Detailed funding history for DirectBio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DirectBio
Investment portfolio details for DirectBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DirectBio
Detailed financials for DirectBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Directbio Comparisons
Peer comparison for DirectBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DirectBio
DirectBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYMVOL, Imperagen and Nanosyn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of enzyme development & designing, biocatalysis, and protein engineering services
|
|
| Locked | Locked | Locked |
An enzyme engineering platform is developed for drug development applications.
|
|
| Locked | Locked | Locked |
Preclinical CRO services in chemistry and biological assays are offered.
|
Detailed competitors of DirectBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Directbio
Complete news archive for DirectBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DirectBio
DirectBio was founded in 2023.
DirectBio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
DirectBio specializes in molecular diagnostics using CRISPR enzymes to detect airborne viruses without amplification, making tests faster, cheaper, and more accurate. The company avoids RNA or DNA extraction and reverse transcription, simplifying processes for applications in hospitals, schools, chicken coops, and biodefense. Based in San Francisco, USA, it serves sectors needing reliable virus monitoring with a focus on indoor environments where infections occur.
DirectBio offers CRISPR Diagnostics.